Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Proper documentation of COPD assessment using the GOLD “ABCD” tool is crucial for implementing guideline-based care and improving patient outcomes.
Emergency Medicine July 24th 2024
The New England Journal of Medicine
The randomized, controlled trial demonstrates that early intervention by pulmonologists for undiagnosed COPD and asthma results in lower health care utilization and improved patient outcomes, compared to usual primary care.
Pulmonology June 20th 2024
Annals of Internal Medicine
In a comprehensive analysis of COPD patients, the use of gabapentinoids was found to be associated with a 1.39 times higher risk of severe exacerbations requiring hospitalization. This finding underscores the need for cautious prescribing of these medications in the COPD population, considering their potential respiratory risks.
Internal Medicine January 24th 2024
ACP Internist
Are you current on the latest treatment modalities for managing dyspnea in severe COPD? Test your knowledge with this quiz and stay ahead in patient care.
Allergy & Immunology September 7th 2023
The study reveals that generic Wixela Inhub is comparable to Advair Diskus in both effectiveness and safety for treating COPD. Consider this cost-effective alternative in your treatment plans.
Clinical Pharmacology August 31st 2023
Uncover the potential of dupilumab in managing COPD patients with type 2 inflammation as this Phase 3 trial reveals fewer exacerbations, improved lung function, and enhanced life quality among the treated cohort.
Allergy & Immunology July 27th 2023